CN105726700A - Method for treating mycoplasma infection - Google Patents

Method for treating mycoplasma infection Download PDF

Info

Publication number
CN105726700A
CN105726700A CN201610159876.XA CN201610159876A CN105726700A CN 105726700 A CN105726700 A CN 105726700A CN 201610159876 A CN201610159876 A CN 201610159876A CN 105726700 A CN105726700 A CN 105726700A
Authority
CN
China
Prior art keywords
parts
herba
mycoplasma infection
chinese medicine
radix
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201610159876.XA
Other languages
Chinese (zh)
Inventor
王磊蕾
刘俊英
别立梅
薛飞
崔艳香
于学俊
孙贵雨
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201610159876.XA priority Critical patent/CN105726700A/en
Publication of CN105726700A publication Critical patent/CN105726700A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/19Acanthaceae (Acanthus family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/47Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/72Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/74Rubiaceae (Madder family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A61L2/04Heat
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2202/00Aspects relating to methods or apparatus for disinfecting or sterilising materials or objects
    • A61L2202/20Targets to be treated
    • A61L2202/26Textiles, e.g. towels, beds, cloths

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a method for treating mycoplasma infection.The method includes keeping underwear sanitary by washing them separately, and boiling the underwear with water for more than 5 minutes; exercising to keep fit and having good rest; taking the Chinese herbal medicine preparation for treating mycoplasma infection, that is, taking the preparation made of burdock, urtica fissa, aster ageratoides, eel grass, Chinese forgetmenot root, urena procumbens, averrhoa carambola leaves, christia obcordata, senecio dianthus franch, ventilago leiocarpa benth, buttonbush root, and cicerbita cyanea with water.Through clinical practice, total efficiency is up to 96%.

Description

A kind of method treating mycoplasma infection
Technical field
The present invention relates to a kind of method treating infectious disease, particularly relate to a kind of method treating mycoplasma infection.
Background technology
Mycoplasma is the minimum microorganism of extracellular existence.Being the class prokaryotic microorganism that lacks cell wall, size is typically between 0.3-0.5um, in height pleomorphism, has spherical, rod, the variform such as thread, branched.It is different from cell, also different from virus.Harm of a great variety, widely distributed, that cause is quite big, relates to multiple fields such as people, animal, plant and insecticide, brings adverse effect to human health and research work.Current western medical treatment mainly applies antibiotics, and along with being on the increase of Resistant strain, drug resistance constantly strengthens, not only weak curative effect, and has bigger toxic and side effects, it is easy to repeatedly, and market still lacks the active drug treating this type of disease.
Summary of the invention
It is an object of the invention to provide a kind of method treating mycoplasma infection.
In mycoplasma infection pathogenic mycoplasma, mycoplasma pneumoniae causes pneumonia;Mycoplasma hominis, Ureaplasma urealyticum and mycoplasma genitalium principal urogenital road infect.Mycoplasma pneumonia is also known as primary atypical pneumonia, and mycoplasma pneumonia all can be fallen ill the whole year, common with winter.Mycoplasma genitalium infection is in recent years newly clear and definite a kind of transmission through sex disease.Adult, mainly through transmission through sex, infects when neonate is then given a birth by mother's reproductive tract.The infection site of adult human male is at mucous membrane of urethra, and women infection site is at cervix uteri.
It is an object of the invention to be achieved through the following technical solutions, the method for this treatment mycoplasma infection specifically includes that
1. attention to hygiene, underwear pants individually to be washed, it is desirable to boiling water more than five minutes.
2. health invigorating, takes a good rest.
3. the Chinese medicine preparation of the treatment mycoplasma infection of the present invention is taken.
The Chinese medicine preparation of the described present invention is made up of the Chinese medicine of following weight portion: Fructus Arctii 6 parts, Herba Girardiniae Palmatae 15 parts, Herba Asteris Ageratoidis 24 parts, Herba vallisneriae Spiralis 11 parts, Herba Sericocalycis Chinensis 15 parts, Radix Phyllanthi cochinchinensis 9 parts, Folium Averrhoae Carambolae 6 parts, Herba Christiae Obcordatae 15 parts, Herba Senecionis Dianthui 5 parts, Radix seu Caulis Verntilaginis Leiocarpae 13 parts, Radix Cephalanthi Occidentalis 6 parts, Cicerbita cyanea (D. Don) beauverd 9 parts.
Preparation method: traditionally make decoction.
Fang Zhong: Fructus Arctii dispelling wind and heat pathogens, lung qi dispersing rash, subduing swelling and detoxicating;Herba Girardiniae Palmatae expelling pathogenic wind from the body surface, promoting the circulation of QI expectorant, Qinghuo Jiedu;The removing toxic substances of Herba Asteris Ageratoidis wind and heat dispersing, eliminating phlegm and relieving cough;Herba vallisneriae Spiralis clearing away summer-heat, removing heat from blood dissipate poison;Herba Sericocalycis Chinensis diuresis removing toxic substances, antiinflammatory;Radix Phyllanthi cochinchinensis clearing away damp-heat, removing toxic substances removing food stagnancy;Folium Averrhoae Carambolae diuresis, heat radiation poison;Herba Christiae Obcordatae relieving stranguria by diuresis, dissipating blood stasis detoxify;Herba Senecionis Dianthui expelling wind and removing dampness, heat-clearing and toxic substances removing, antipruritic;Radix seu Caulis Verntilaginis Leiocarpae benefiting vital QI and blood, dispelling, collateral-activating;Radix Cephalanthi Occidentalis clearing away heat and eliminating dampness, dissipating blood stasis for subsidence of swelling;Cicerbita cyanea (D. Don) beauverd heat clearing and inflammation relieving, invigorating the spleen and regulating the stomach.
Clinical data
1, all cases is from my Out-patient Department, totally 100 example of December 1 years January in 2011, is randomly divided into Chinese drug-treated group 50 example using the present invention to treat mycoplasma infection, Western medicine group 50 example.
2, diagnosis method is made a definite diagnosis according to mycoplasma infection symptom and laboratory inspection.
3, exclusion standard (1) has complication to exist;(2) there is other medicines application history in nearly 7 days;(3) do not carry out laboratory inspection and do not make a definite diagnosis person completely;(4) fail to complete person's course for the treatment of by doctor's advice.
3, Therapeutic Method treatment group: treat the method treatment of mycoplasma infection by the present invention.Treat in the 4th in the method for mycoplasma infection in the present invention, weigh Fructus Arctii 6 grams, Herba Girardiniae Palmatae 15 grams, Herba Asteris Ageratoidis 24 grams, Herba vallisneriae Spiralis 11 grams, Herba Sericocalycis Chinensis 15 grams, Radix Phyllanthi cochinchinensis 9 grams, Folium Averrhoae Carambolae 6 grams, Herba Christiae Obcordatae 15 grams, Herba Senecionis Dianthui 5 grams, Radix seu Caulis Verntilaginis Leiocarpae 13 grams, Radix Cephalanthi Occidentalis 6 grams, Cicerbita cyanea (D. Don) beauverd 9 grams, traditionally make decoction, divide and sooner or later take for twice, within 7 days, be a course for the treatment of.
Matched group: western medical treatment method routinely is treated, 7 days is a course for the treatment of.Treat two courses for the treatment of continuously for two groups.
4, criterion of therapeutical effect recovery from illness: clinical symptom disappearance, lab testing mycoplasma is negative;Effective: lab testing is turned out cloudy, but clinical symptoms is not wholly absent;Invalid: clinical symptoms is not improved, lab testing does not turn negative.
5, therapeutic outcome
Group Number of cases Recovery from illness Effective Invalid Total effective rate (%)
Treatment group 50 30 18 2 96
Matched group 50 15 15 20 60
By above therapeutic outcome it can be seen that the therapeutic effect for the treatment of group is significantly better than matched group.
Detailed description of the invention
The method of this treatment mycoplasma infection specifically includes that
1. attention to hygiene, underwear pants individually to be washed, it is desirable to boiling water more than five minutes.
2. health invigorating, takes a good rest.
3. the Chinese medicine preparation of the treatment mycoplasma infection of the present invention is taken.
The Chinese medicine preparation of the described present invention is made up of the Chinese medicine of following weight portion: Fructus Arctii 6 grams, Herba Girardiniae Palmatae 15 grams, Herba Asteris Ageratoidis 24 grams, Herba vallisneriae Spiralis 11 grams, Herba Sericocalycis Chinensis 15 grams, Radix Phyllanthi cochinchinensis 9 grams, Folium Averrhoae Carambolae 6 grams, Herba Christiae Obcordatae 15 grams, Herba Senecionis Dianthui 5 grams, Radix seu Caulis Verntilaginis Leiocarpae 13 grams, Radix Cephalanthi Occidentalis 6 grams, Cicerbita cyanea (D. Don) beauverd 9 grams, traditionally makes decoction.

Claims (2)

1. the method treating mycoplasma infection, it is characterised in that the method includes:
1. attention to hygiene, underwear pants individually to be washed, it is desirable to boiling water more than five minutes;
2. health invigorating, takes a good rest;
3. the Chinese medicine preparation of the treatment mycoplasma infection of the present invention is taken.
2. a kind of method treating mycoplasma infection as claimed in claim 1, it is characterised in that described Chinese medicine preparation is made up of the Chinese medicine of following weight portion: Fructus Arctii 6 parts, Herba Girardiniae Palmatae 15 parts, Herba Asteris Ageratoidis 24 parts, Herba vallisneriae Spiralis 11 parts, Herba Sericocalycis Chinensis 15 parts, Radix Phyllanthi cochinchinensis 9 parts, Folium Averrhoae Carambolae 6 parts, Herba Christiae Obcordatae 15 parts, Herba Senecionis Dianthui 5 parts, Radix seu Caulis Verntilaginis Leiocarpae 13 parts, Radix Cephalanthi Occidentalis 6 parts, Cicerbita cyanea (D. Don) beauverd 9 parts.
CN201610159876.XA 2016-03-09 2016-03-09 Method for treating mycoplasma infection Pending CN105726700A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610159876.XA CN105726700A (en) 2016-03-09 2016-03-09 Method for treating mycoplasma infection

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610159876.XA CN105726700A (en) 2016-03-09 2016-03-09 Method for treating mycoplasma infection

Publications (1)

Publication Number Publication Date
CN105726700A true CN105726700A (en) 2016-07-06

Family

ID=56250910

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610159876.XA Pending CN105726700A (en) 2016-03-09 2016-03-09 Method for treating mycoplasma infection

Country Status (1)

Country Link
CN (1) CN105726700A (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101862393A (en) * 2010-05-12 2010-10-20 韩延华 Chinese medicinal composition for treating ureaplasma urealyticum infection and preparation method thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101862393A (en) * 2010-05-12 2010-10-20 韩延华 Chinese medicinal composition for treating ureaplasma urealyticum infection and preparation method thereof

Similar Documents

Publication Publication Date Title
CN103933468A (en) Traditional Chinese medicine for treating acute pancreatitis
CN103301288B (en) Traditional Chinese medicine composition for treating gouty arthritis
CN102755559B (en) Traditional Chinese medicine composition for treating non-gonococcal urethritis
CN107661423B (en) Medicine for treating rhinitis and its pillow
CN104225218A (en) Traditional Chinese medicine preparation for chronic urinary infection treatment
CN105726700A (en) Method for treating mycoplasma infection
CN104147252A (en) Traditional Chinese medicine preparation for treating hepatitis
CN103623302A (en) Traditional Chinese medicine composition for treating non-gonococcal urethritis
CN103860894B (en) A kind of medicine for the treatment of chronic prostatitis
CN105435109A (en) Rheumatalgia treating traditional Chinese medicine composition
CN104248725A (en) Traditional Chinese medicine for treating acute gonorrhea
CN102743686A (en) Pelvic inflammation-clearing capsule
CN102688456B (en) Chinese medicinal composition for treating chronic prostatitis
CN105343243A (en) Traditional Chinese medicine composition for treating rheumatoid arthritis and nursing method of traditional Chinese medicine composition for treating rheumatoid arthritis
CN102430057B (en) Medicinal composition for treating rheumatic pain
CN103610906A (en) Pharmaceutical composition for treating pain from rheumatism
CN105381177A (en) External use traditional Chinese medicine for treating sweet stains
CN104491494A (en) External pharmaceutical composition for treating pain from rheumatism
CN105770759A (en) Traditional Chinese medicine for treating appendicitis
CN105056053A (en) Pharmaceutical preparation for treating leuconychia
CN105412646A (en) Traditional Chinese medicinal composition for treating exogenous fever and application of traditional Chinese medicinal composition
CN103845499B (en) A kind of Chinese medicine composition for the treatment of chronic prostatitis
CN104147263A (en) Traditional Chinese medicine for treating neurodermatitis
CN102861245A (en) Medicine for preventing and treating gout disease
CN109106833A (en) A kind of preparation method of anti-appendicitis curing

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20160706